Human Norovirus Evolution in a Chronically Infected Host

ABSTRACT Typically, human noroviruses cause symptoms of acute gastroenteritis for 2 to 4 days. Often, the virions are shed in stool for several days after the symptoms recede, which in turn can lead to further contamination and transmission. Moreover, a number of reports have considered that chronic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sylvie Y. Doerflinger, Stefan Weichert, Anna Koromyslova, Martin Chan, Christian Schwerk, Ruediger Adam, Stefan Jennewein, Grant S. Hansman, Horst Schroten
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2017
Materias:
Acceso en línea:https://doaj.org/article/13c3b435143a4770bc5720006b0b6541
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:13c3b435143a4770bc5720006b0b6541
record_format dspace
spelling oai:doaj.org-article:13c3b435143a4770bc5720006b0b65412021-11-15T15:21:45ZHuman Norovirus Evolution in a Chronically Infected Host10.1128/mSphere.00352-162379-5042https://doaj.org/article/13c3b435143a4770bc5720006b0b65412017-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00352-16https://doaj.org/toc/2379-5042ABSTRACT Typically, human noroviruses cause symptoms of acute gastroenteritis for 2 to 4 days. Often, the virions are shed in stool for several days after the symptoms recede, which in turn can lead to further contamination and transmission. Moreover, a number of reports have considered that chronic norovirus infections, i.e., lasting months and years, might even function as reservoirs for the generation of novel strains that can escape the herd immunity or have modified binding interactions with histo-blood group antigens (HBGAs). In this study, we analyzed noroviruses isolated from a patient who has presented a chronic infection for more than 6 years. We found that the isolated capsid sequences clustered into two main genetic types (termed A and B), despite a plethora of capsid quasi-sequences. Furthermore, the two genetic types corresponded well with distinct antigenicities. On the other hand, we showed that numerous amino acid substitutions on the capsid surface of genetic types A and B did not alter the HBGA binding profiles. However, divergent binding profiles for types A and B were observed with human milk oligosaccharides (HMOs), which structurally mimic HBGAs and may act as natural antivirals. Importantly, the isolated capsid sequences only had approximately 90% amino acid identity with other known sequences, which suggested that transmission of these chronic noroviruses could be limited. IMPORTANCE The norovirus genogroup II genotype 4 (GII.4) variants have approximately 5% divergence in capsid amino acid identity and have dominated over the past decade. The precise reason(s) for the GII.4 emergence and persistence in the human population is still unknown, but some studies have suggested that chronically infected patients might generate novel variants that can cause new epidemics. We examined GII.4 noroviruses isolated from an immunocompromised patient with a long-term infection. Numerous norovirus capsid quasi-species were isolated during the 13-month study. The capsid quasi-species clustered into two genetic and antigenic types. However, the HBGA binding profiles were similar between the two antigenic clusters, indicating that the amino acid substitutions did not alter the HBGA binding interactions. The isolated sequences represented two new GII.4 variants, but similar sequences were not found in the database. These results indicated that chronically infected patients might not generate novel noroviruses that cause outbreaks.Sylvie Y. DoerflingerStefan WeichertAnna KoromyslovaMartin ChanChristian SchwerkRuediger AdamStefan JenneweinGrant S. HansmanHorst SchrotenAmerican Society for Microbiologyarticlechronic infectionevolutionnorovirusMicrobiologyQR1-502ENmSphere, Vol 2, Iss 2 (2017)
institution DOAJ
collection DOAJ
language EN
topic chronic infection
evolution
norovirus
Microbiology
QR1-502
spellingShingle chronic infection
evolution
norovirus
Microbiology
QR1-502
Sylvie Y. Doerflinger
Stefan Weichert
Anna Koromyslova
Martin Chan
Christian Schwerk
Ruediger Adam
Stefan Jennewein
Grant S. Hansman
Horst Schroten
Human Norovirus Evolution in a Chronically Infected Host
description ABSTRACT Typically, human noroviruses cause symptoms of acute gastroenteritis for 2 to 4 days. Often, the virions are shed in stool for several days after the symptoms recede, which in turn can lead to further contamination and transmission. Moreover, a number of reports have considered that chronic norovirus infections, i.e., lasting months and years, might even function as reservoirs for the generation of novel strains that can escape the herd immunity or have modified binding interactions with histo-blood group antigens (HBGAs). In this study, we analyzed noroviruses isolated from a patient who has presented a chronic infection for more than 6 years. We found that the isolated capsid sequences clustered into two main genetic types (termed A and B), despite a plethora of capsid quasi-sequences. Furthermore, the two genetic types corresponded well with distinct antigenicities. On the other hand, we showed that numerous amino acid substitutions on the capsid surface of genetic types A and B did not alter the HBGA binding profiles. However, divergent binding profiles for types A and B were observed with human milk oligosaccharides (HMOs), which structurally mimic HBGAs and may act as natural antivirals. Importantly, the isolated capsid sequences only had approximately 90% amino acid identity with other known sequences, which suggested that transmission of these chronic noroviruses could be limited. IMPORTANCE The norovirus genogroup II genotype 4 (GII.4) variants have approximately 5% divergence in capsid amino acid identity and have dominated over the past decade. The precise reason(s) for the GII.4 emergence and persistence in the human population is still unknown, but some studies have suggested that chronically infected patients might generate novel variants that can cause new epidemics. We examined GII.4 noroviruses isolated from an immunocompromised patient with a long-term infection. Numerous norovirus capsid quasi-species were isolated during the 13-month study. The capsid quasi-species clustered into two genetic and antigenic types. However, the HBGA binding profiles were similar between the two antigenic clusters, indicating that the amino acid substitutions did not alter the HBGA binding interactions. The isolated sequences represented two new GII.4 variants, but similar sequences were not found in the database. These results indicated that chronically infected patients might not generate novel noroviruses that cause outbreaks.
format article
author Sylvie Y. Doerflinger
Stefan Weichert
Anna Koromyslova
Martin Chan
Christian Schwerk
Ruediger Adam
Stefan Jennewein
Grant S. Hansman
Horst Schroten
author_facet Sylvie Y. Doerflinger
Stefan Weichert
Anna Koromyslova
Martin Chan
Christian Schwerk
Ruediger Adam
Stefan Jennewein
Grant S. Hansman
Horst Schroten
author_sort Sylvie Y. Doerflinger
title Human Norovirus Evolution in a Chronically Infected Host
title_short Human Norovirus Evolution in a Chronically Infected Host
title_full Human Norovirus Evolution in a Chronically Infected Host
title_fullStr Human Norovirus Evolution in a Chronically Infected Host
title_full_unstemmed Human Norovirus Evolution in a Chronically Infected Host
title_sort human norovirus evolution in a chronically infected host
publisher American Society for Microbiology
publishDate 2017
url https://doaj.org/article/13c3b435143a4770bc5720006b0b6541
work_keys_str_mv AT sylvieydoerflinger humannorovirusevolutioninachronicallyinfectedhost
AT stefanweichert humannorovirusevolutioninachronicallyinfectedhost
AT annakoromyslova humannorovirusevolutioninachronicallyinfectedhost
AT martinchan humannorovirusevolutioninachronicallyinfectedhost
AT christianschwerk humannorovirusevolutioninachronicallyinfectedhost
AT ruedigeradam humannorovirusevolutioninachronicallyinfectedhost
AT stefanjennewein humannorovirusevolutioninachronicallyinfectedhost
AT grantshansman humannorovirusevolutioninachronicallyinfectedhost
AT horstschroten humannorovirusevolutioninachronicallyinfectedhost
_version_ 1718428113419894784